abiraterone vs ethinyl estradiol/levonorgestrel

PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.

Side-by-side comparison of abiraterone and ethinyl estradiol/levonorgestrel. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

Drug Class
abiraterone CYP17 Inhibitor
ethinyl estradiol/levonorgestrel Combined Oral Contraceptive
Type
abiraterone Prescription
ethinyl estradiol/levonorgestrel Prescription
Summary
abiraterone

Abiraterone (Zytiga) is a medicine used with prednisone to treat prostate cancer that has spread. It works by lowering the amount of androgen your body makes.

ethinyl estradiol/levonorgestrel

Amethia is a birth control pill that you take every day to prevent pregnancy. It contains two hormones, estrogen and progestin.

What It Treats
abiraterone

Abiraterone is used to treat prostate cancer that has spread to other parts of the body. It is for cancers that are castration-resistant, meaning they no longer respond to hormone therapy alone. It is also used for high-risk castration-sensitive prostate cancer. You will take this medicine with prednisone.

ethinyl estradiol/levonorgestrel

Amethia is used by women to prevent pregnancy. It contains two hormones that work together to stop you from getting pregnant. You must take it exactly as directed to prevent pregnancy.

How It Works
abiraterone

Abiraterone blocks an enzyme called CYP17, which your body needs to make androgens. Androgens can help prostate cancer grow. By blocking this enzyme, abiraterone lowers androgen levels and slows cancer growth.

ethinyl estradiol/levonorgestrel

Amethia works by preventing ovulation (the release of an egg from the ovary). It also thickens the mucus in the cervix, making it harder for sperm to reach the egg. The hormones in Amethia also change the lining of the uterus.

Common Side Effects
abiraterone
  • Feeling tired
  • Joint pain
  • High blood pressure
  • Feeling sick to your stomach
  • Swelling
ethinyl estradiol/levonorgestrel
  • Irregular or heavy uterine bleeding
  • Weight gain
  • Acne
  • Nausea
  • Breast tenderness
FAERS Reports
abiraterone
  • Death 1,390
  • Fatigue 1,023
  • Hot Flush 678
  • Asthenia 562
  • Disease Progression 561
ethinyl estradiol/levonorgestrel
  • Feeling sick to your stomach 15
  • Throwing up 13
  • Stomach pain 10
  • Exposure to the drug during pregnancy 9
  • Feeling tired 9
Serious Warnings
abiraterone

Abiraterone can cause problems with mineralocorticoid excess, like high blood pressure, low potassium, and fluid retention. If you have heart problems, your doctor will monitor you closely. This medicine can also cause liver problems, which can be severe. Your doctor will check your liver function regularly. Do not take abiraterone with radium Ra 223 dichloride. Abiraterone can harm an unborn baby, so men should use effective birth control if their partner can get pregnant.

ethinyl estradiol/levonorgestrel

Cigarette smoking increases your risk of serious heart problems from birth control pills. This risk is higher if you are over 35 and smoke. If you are over 35 and smoke, you should not use Amethia.

Pregnancy
abiraterone

Abiraterone can cause harm to an unborn baby. Men who are taking abiraterone should use effective birth control during treatment and for 3 weeks after the last dose if their partner is able to get pregnant. It is not known if abiraterone passes into breast milk.

ethinyl estradiol/levonorgestrel

Amethia should not be used during pregnancy. It is also not recommended if you are breastfeeding, as it can reduce milk production and small amounts of the drug can pass into breast milk.

Also Compare, Nearby Drugs

How to Read This abiraterone vs ethinyl estradiol/levonorgestrel Comparison

abiraterone is classified in the CYP17 Inhibitor drug class, while ethinyl estradiol/levonorgestrel sits within the Combined Oral Contraceptive class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, abiraterone has 4,214 submissions while ethinyl estradiol/levonorgestrel has 56. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for abiraterone or ethinyl estradiol/levonorgestrel.

Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.